Fred Colen, Neovasc - Treatment of Advanced Heart Disease | LSI Europe '22

Neovasc's products include Reducer, for the treatment of refractory angina and Tiara for the transcatheter treatment of mitral regurgitation.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Fred Colen
Fred Colen
CEO, Neovasc